Emotional Impact of Hypoglycemia and Use of Glucagon: Perspectives of People with Type 1 Diabetes
Introduction: Severe hypoglycemia is an ongoing barrier to achieving glycemic targets. Glucagon is an effective, yet underutilized treatment for severe…
Validation of Fear of Hypoglycemia Screener: Results from the T1D Exchange Online Survey
Objective: To examine reliability and validity of a newly developed fear of hypoglycemia (FoH) screener as a practical and actionable…
Factors Associated with Optimal Glycemic Control in Children and Adolescents with Type 1 Diabetes: Real-World U.S. Multicenter Study
Background: Management of type 1 diabetes (T1D) involves achieving glycemic targets to avoid complications. However, despite advancements in diabetes technology…
Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic.
Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative…
Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes.
We commend Gregory and colleagues for their well-designed prospective study to quantify and contextualize the risk for coronavirus disease 2019…
Patient demographics and clinical outcomes among type 1 diabetes (T1D) patients using Continuous Glucose Monitors (CGMs): real world evidence from a large U.S. collaborative.
CGM devices have been shown to improve glycemic control in patients with T1D. Despite existing clinical evidence and improved performance…
Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes.
Background Diabetes is a risk factor for poor COVID-19 outcomes, but pediatric patients with type 1 diabetes are poorly represented…
“I’ve Had an Alarm Set for 3:00 a.m. for Decades”: The Impact of Type 1 Diabetes on Sleep
There is a dearth of research characterizing the impact on a caregiver’s sleep when caring for a minor with type…
Inequities in Diabetic Ketoacidosis among Patients with Type 1 diabetes and COVID-19: Data from 52 US Clinical Centers
Objective We examined whether diabetic ketoacidosis (DKA), a serious complication of type 1 diabetes (T1D) was more prevalent among Non-Hispanic…
Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) global pandemic has marked 2020. There have been initial reports on coronavirus…
